Exhibit 99.1 SS&C Technologies Releases Q3 2026 Financial Results Q3 2026 GAAP
Exhibit 99.1 SS&C Technologies Releases Q3 2026 Financial Results Q3 2026 GAAP revenue $1,690.0 million, up 7.8%, Fully Diluted GAAP Earnings Per Share $0.83 Adjusted revenue $1,691.1 million, up 7.8%, Adjusted Diluted Earnings Per Share $1.78, up 14.8% WINDSOR, CT, October 22, 2026 (BUSINESS WIRE) -- SS&C Technologies Holdings, Inc. (NASDAQ: SSNC), a global provider of investment, financial and healthcare technology and technology-enabled services, today announced its financial results for the third quarter ended September 30, 2026.
(1) Reflects non-GAAP tax rates of 22.5% for the three and nine months ended September 30, 2026 and 22.0% for the three and nine months ended September 30, 2025. See Note 4 for more information. Third Quarter 2026 Highlights: • Q3 2026 GAAP Revenue growth and Adjusted Revenue growth were 7.8 percent. • Q3 2026 Adjusted Organic Revenue Growth was 5.2 percent. • Net cash generated from operating activities of $1,216.3 million for the nine months ended September 30, 2026, up 10.4 percent compared to the same period in 2025. • Returned $225.3 million to shareholders in Q3 2026, which included 1.9 million shares repurchased for $154.8 million and $70.5 million in common stock dividends. • Paid down $130.0 million in debt, bringing our net leverage ratio to 2.63x • Record adjusted consolidated EBITDA of $674.8 million for Q3 2026, up 9.0 percent. Adjusted consolidated EBITDA margin for Q3 2026 was 39.9 percent. • GAAP operating income margin for Q3 2026 was 24.2 percent and GAAP net income of $198.9 million for Q3 2026. • Adjusted diluted earnings per share was $1.78, up 14.8 percent. • In August, SS&C increased our common stock dividend to $1.20 annually, an 11.1 percent increase. "SS&C delivered another quarter of strong results, with Q3 organic revenue growth of 5.2%, record adjusted consolidated EBITDA of $674.8 million, and margins of 39.9%, keeping us on track to achieve our full-year goals," said Bill Stone, Chairman and Chief Executive Officer. "In September, we hosted over 1,000 financial services and healthcare leaders at our annual SS&C Deliver conference, and it was clear that holistic transformation of our clients' operating models is a top priority. As we harness emerging technologies like agentic AI and tokenization, SS&C is evolving in step with our clients—partnering with them, supporting them, and shaping the future together." 1 Operating Cash Flow SS&C generated net cash from operating activities of $1,216.3 million for the nine months ended September 30, 2026, compared to $1,101.3 million for the same period in 2025, a 10.4% increase. SS&C ended the third quarter with $525.4 million in cash and cash equivalents and $7,483.5 million in gross debt. SS&C’s consolidated net leverage ratio as defined in our credit agreement stood at 2.63 times consolidated EBITDA as of September 30, 2026. SS&C’s net secured leverage ratio stood at 1.59 times consolidated EBITDA as of September 30, 2026. Guidance
1 Interest expense is net of deferred financing cost amortization and original issue discount SS&C does not provide reconciliations of guidance for Adjusted Revenues and Adjusted Net Income to comparable GAAP measures, in reliance on the unreasonable efforts exception provided under Item 10(e)(1)(i)(B) of Regulation S-K. SS&C is unable, without unreasonable efforts, to forecast certain items required to develop meaningful comparable GAAP financial measures. These items include acquisition transactions and integration, foreign exchange rate changes, as well as other non-cash and other adjustments as defined under the Company’s Credit agreement, that are difficult to predict in advance in order to include in a GAAP estimate. The unavailable information could have a significant impact on Q4 2026 and FY 2026 GAAP financial results. Non-GAAP Financial Measures Adjusted revenue, adjusted operating income, adjusted consolidated EBITDA, adjusted net income and adjusted diluted earnings per share are non-GAAP measures. See the accompanying notes for the reconciliations and definitions for each of these non-GAAP measures and the reasons our management believes these measures provide useful information to investors regarding our financial condition and results of operations. All references above to net income, diluted earnings per share, adjusted operating income, adjusted consolidated EBITDA, and adjusted diluted earnings per share are attributable to SS&C. 2 Earnings Call and Press Release
SS&C’s third quarter 2026 earnings call will take place at 5:00 p.m. eastern time today, October 22, 2026. The call will discuss third quarter 2026 results. Interested parties may visitinvestor.ssctech.comto access the live webcast and view accompanying slides. The call will be available for replay via the webcast on SS&C’s website; access:https://investor.ssctech.com/financials/quarterly- results/default.aspx
Certain information contained in this press release, including information relating to, among other things, the Company’s financial guidance for the fourth quarter and full year of 2026 constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, expectations, intentions, projections, developments, future events, performance, underlying assumptions, and other statements that are other than statements of historical facts. Without limiting the foregoing, the words “believes”, “anticipates”, “plans”, “expects”, “estimates”, “projects”, “forecasts”, “may”, “assume”, “intend”, “will”, “continue”, “opportunity”, “predict”, “potential”, “future”, “guarantee”, “likely”, “target”, “indicate”, “would”, “could” and “should” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements are accompanied by such words. Such statements reflect management’s best judgment based on factors currently known but are subject to risks and uncertainties, which could cause actual results to differ materially from those anticipated. Such risks and uncertainties include, but are not limited to, the state of the economy and the financial services industry and other industries in which the Company’s clients operate, the Company’s ability to realize anticipated benefits from its acquisitions, the effect of customer consolidation on demand for the Company’s products and services, the variability of revenue as a result of activity in the securities markets, the focus of the Company’s business on the asset management industry, the ability to retain and attract clients, the intensity of competition with respect to the Company’s products and services, risks from cyber-attacks, breaches of digital security, IT system failures and network disruptions, risks associated with third party providers, fluctuations in the Company’s operating results, terrorist activities and other catastrophic events, risks associated with the Company’s foreign operations, privacy concerns relating to the collection and storage of personal information, evolving regulations and increased scrutiny from regulators, the Company’s ability to protect intellectual property assets and litigation regarding intellectual property rights, delays in product development, investment decisions concerning cash balances, tax risks, risks associated with the Company’s joint ventures, changes in accounting standards, evolving regulation and scrutiny from regulators, the Company’s exposure to litigation and other claims, risks related to the Company’s substantial indebtedness, and the market price of the Company’s stock prevailing from time to time, and the risks discussed in the “Risk Factors” section of the Company’s most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, which are on file with the Securities and Exchange Commission and can also be accessed on our website. Such “Risk Factors”, among others, could cause actual results to differ materially from those indicated by forward-looking statements made herein and presented elsewhere by management from time to time. Undue reliance should not be placed on any such forward-looking statements. Forward-looking statements speak only as of the date on which they are made and, except to the extent required by applicable securities laws, we undertake no obligation to update or revise any forward-looking statements. 3 About SS&C Technologies
SS&C is a leading provider of mission-critical, AI-powered technology and services empowering financial services and healthcare organizations to work smarter, faster, and securely. Founded in 1986, SS&C is headquartered in Windsor, Connecticut, and has offices worldwide. More than 23,000 financial services and healthcare organizations, from the world's largest companies to small and mid-market firms, rely on SS&C for expertise, scale and technology.
E-mail:[email protected] 4 SS&C Technologies Holdings, Inc. and Subsidiaries Condensed Consolidated Statements of Comprehensive Income (in millions, except per share data) (unaudited)
5 SS&C Technologies Holdings, Inc. and Subsidiaries Condensed Consolidated Balance Sheets (in millions) (unaudited)
Assets September 30, December 31, Current assets: 2026 2025 ────────────────────────────────────────────────────────────────────────────── Cash and cash $ 525.4 $ 462.1 equivalents Funds receivable and funds held on 3,846.5 3,799.5 behalf of clients Accounts receivable, 1,033.7 978.7 net Contract asset 57.4 49.2 Prepaid expenses and other current 183.4 193.7 assets Restricted cash 2.5 4.5 Total current assets 5,648.9 5,487.7 Property, plant and 280.3 289.5 equipment, net Operating lease 217.9 233.3 right-of-use assets Investments 171.3 174.4 Unconsolidated 247.3 307.7 affiliates Contract asset 140.2 133.1 Goodwill 9,928.1 9,991.3 Intangible and other 3,781.2 4,094.7 assets, net Total assets $ 20,415.2 $ 20,711.7 Liabilities and Equity Current liabilities: Current portion of $ 2,260.0 $ 25.0 long-term debt (1) Client funds 3,846.5 3,799.5 obligations Accounts payable 71.7 87.2 Income taxes payable — 23.3 Accrued employee compensation and 288.1 348.9 benefits Interest payable 16.7 31.6 Other accrued expenses 278.2 303.4 Deferred revenue 444.7 492.4 Total current 7,205.9 5,111.3 liabilities Long-term debt, net of 5,189.5 7,408.4 current portion Operating lease 205.4 213.2 liabilities Other long-term 198.4 190.2 liabilities Deferred income taxes 848.3 846.8 Total liabilities 13,647.5 13,769.9 SS&C stockholders' 6,698.7 6,887.6 equity Noncontrolling interest 69.0 54.2 Total equity 6,767.7 6,941.8 Total liabilities and $ 20,415.2 $ 20,711.7 equity
(1) $2.0 billion of Senior Notes has been classified as current given the stated maturity of September 30, 2027. We are actively addressing this maturity and believe refinancing the Senior Notes is probable of occurring during the 4 th quarter of 2026. 6 SS&C Technologies Holdings, Inc. and Subsidiaries Condensed Consolidated Statements of Cash Flows (in millions) (unaudited)
Cash flow from Nine Months Ended operating September 30, activities: 2026 2025 ────────────────────────────────────────────────────────────────────────────── Net income $ 659.7 $ 604.7 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and 544.7 521.1 amortization Equity in earnings of unconsolidated 40.8 7.7 affiliates, net Distributions received from 16.9 — unconsolidated affiliates Stock-based compensation 185.8 172.9 expense Unrealized net losses on 2.2 2.4 investments Amortization of debt financing 5.5 4.9 costs Loss on extinguishment of 1.0 2.2 debt Loss on sale or disposition of 2.0 0.5 property and equipment Deferred income 1.3 46.8 taxes Provision for 15.0 12.0 credit losses Changes in operating assets and liabilities, excluding effects from acquisitions:
Accounts receivable (73.3 ) (54.5 ) Prepaid expenses (14.6 ) 22.0 and other assets Contract assets (15.0 ) (29.1 ) Accounts payable (31.5 ) (16.7 ) Accrued expenses and other (72.6 ) (48.1 ) liabilities Income taxes (0.3 ) (98.8 ) prepaid and payable Deferred revenue (51.3 ) (48.7 ) Net cash provided by operating 1,216.3 1,101.3 activities Cash flow from investing activities: Business acquisitions, net (0.2 ) (5.9 ) of cash acquired Additions to property and (37.0 ) (70.3 ) equipment Proceeds from sale of property and 2.2 5.7 equipment Additions to capitalized (190.2 ) (155.5 ) software Investments in (7.5 ) (2.5 ) securities Proceeds from sales / maturities of 7.7 0.8 investments Distributions received from (contributions to) 2.6 (9.8 ) unconsolidated affiliates Collection of other non-current 8.1 7.9 receivables Net cash used in investing (214.3 ) (229.6 ) activities Cash flow from financing activities: Cash received from 450.0 122.0 debt borrowings Repayments of debt (440.0 ) (545.1 ) Net (decrease) increase in client (323.3 ) 269.4 funds obligations Proceeds from exercise of stock 86.0 362.4 options Withholding taxes paid related to equity (81.7 ) (73.2 ) award net share settlement Purchases of common (760.5 ) (717.3 ) stock for treasury Dividends paid on (199.8 ) (188.3 ) common stock Proceeds from (distributions to) 14.9 (21.8 ) noncontrolling interests Net cash used in financing (1,254.4 ) (791.9 ) activities Effect of exchange rate changes on cash, (9.6 ) 9.8 cash equivalents and restricted cash Net (decrease) increase in cash, cash (262.0 ) 89.6 equivalents and restricted cash Cash, cash equivalents and restricted cash and cash 3,573.8 3,370.5 equivalents, beginning of period Cash, cash equivalents and restricted $ 3,311.8 $ 3,460.1 cash and cash equivalents, end of period Reconciliation of cash, cash equivalents and restricted cash and cash equivalents:
Cash and cash $ 525.4 $ 388.3 equivalents Restricted cash and 2.5 2.5 cash equivalents Restricted cash and cash equivalents included in funds receivable and 2,783.9 3,069.3 funds held on behalf of clients $ 3,311.8 $ 3,460.1
7 SS&C Technologies Holdings, Inc. and Subsidiaries Disclosures Relating to Non- GAAP Financial Measures Note 1. Reconciliation of Revenues to Adjusted Revenues Adjusted revenues represents revenues adjusted to include a) amounts that would have been recognized if deferred revenue were not adjusted to fair value at the date of acquisition and b) amounts that would have been recognized if not for adjustments to deferred revenue and retained earnings related to the adoption of ASC 606. Adjusted revenues is presented because we use this measure to evaluate performance of our business against prior periods and believe it is a useful indicator of the underlying performance of our business. Adjusted revenues is not a recognized term under generally accepted accounting principles (“GAAP”). Adjusted revenues does not represent revenues, as that term is defined under GAAP, and should not be considered as an alternative to revenues as an indicator of our operating performance. Adjusted revenues as presented herein is not necessarily comparable to similarly titled measures presented by other companies. Below is a reconciliation of adjusted revenues to revenues, the GAAP measure we believe to be most directly comparable to adjusted revenues.
The following is a breakdown of technology-enabled services and license, maintenance and related revenues and adjusted technology-enabled services and license, maintenance and related revenues.
8 Note 2. Reconciliation of Operating Income to Adjusted Operating Income Adjusted operating income represents operating income adjusted for amortization of intangible assets, stock-based compensation, purchase accounting adjustments for deferred revenue and related costs, ASC 606 adoption impact and other expenses. Adjusted operating income is presented because we use this measure to evaluate performance of our business and believe it is a useful indicator of our underlying performance. Adjusted operating income is not a recognized term under GAAP. Adjusted operating income does not represent operating income, as that term is defined under GAAP, and should not be considered as an alternative to operating income as an indicator of our operating performance. Adjusted operating income as presented herein is not necessarily comparable to similarly titled measures by other companies. The following is a reconciliation between adjusted operating income and operating income, the GAAP measure we believe to be most directly comparable to adjusted operating income.
(1) Other includes additional expenses and income that are permitted to be excluded per the terms of our Credit Agreement from Consolidated EBITDA, a financial measure used in calculating our covenant compliance. (2) Adjusted operating income attributable to noncontrolling interest represents the proportionate share of adjusted operating income of DomaniRx, LLC (a consolidated joint venture) retained by our joint venture partners. 9 Note 3. Reconciliation of Net Income to EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA EBITDA represents net income before interest expense, income taxes, depreciation and amortization. Consolidated EBITDA, defined under our Credit Agreement entered into in April 2018, as amended, is used in calculating covenant compliance, and is EBITDA adjusted for certain items. Consolidated EBITDA is calculated by subtracting from or adding to EBITDA items of income or expense described below. Adjusted Consolidated EBITDA is calculated by subtracting acquired EBITDA (as defined below) from Consolidated EBITDA. EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA are presented because we use these measures to evaluate performance of our business and believe them to be useful indicators of an entity’s debt capacity and its ability to service debt. EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA are not recognized terms under GAAP and should not be considered in isolation or as alternatives to operating income, net income or cash flows from operating activities as indicators of our operating performance. These measures are not necessarily comparable to similarly titled measures by other companies. The following is a reconciliation of EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA to net income.
(1) Acquired EBITDA reflects the EBITDA impact of significant businesses that were acquired during the last twelve months as if the acquisition occurred at the beginning of the trailing twelve-month period, as well as cost savings enacted in connection with acquisitions. (2) Investment gains includes unrealized fair value adjustments of investments and dividend income received on investments. (3) Other includes additional expenses and income that are permitted to be excluded per the terms of our Credit Agreement from Consolidated EBITDA, a financial measure used in calculating our covenant compliance, and includes a loss on the sale of fixed assets of $33.3 million during the twelve months ended September 30, 2026. (4) Adjusted Consolidated EBITDA attributable to noncontrolling interest represents the proportionate share of adjusted Consolidated EBITDA of DomaniRx, LLC (a consolidated joint venture) retained by our joint venture partners. 10 Note 4. Reconciliation of Net Income to Adjusted Net Income and Diluted Earnings Per Share Attributable to SS&C to Adjusted Diluted Earnings Per Share Attributable to SS&C Adjusted net income and adjusted diluted earnings per share attributable to SS&C represent net income and earnings per share attributable to SS&C before amortization of intangible assets and deferred financing costs, stock-based compensation, purchase accounting adjustments and other items. We consider adjusted net income and adjusted diluted earnings per share attributable to SS&C to be important to management and investors because they represent our operational performance exclusive of the effects of amortization of intangible assets and deferred financing costs, stock-based compensation, purchase accounting adjustments, loss on extinguishment of debt and other items, that are not operational in nature or comparable to those of our competitors. Adjusted net income and adjusted diluted earnings per share are not recognized terms under GAAP. Adjusted net income and adjusted diluted earnings per share do not represent net income or diluted earnings per share, as those terms are defined under GAAP, and should not be considered as alternatives to net income or diluted earnings per share as indicators of our operating performance. Adjusted net income and adjusted diluted earnings per share attributable to SS&C as presented herein are not necessarily comparable to similarly titled measures presented by other companies. Below is a reconciliation of adjusted net income and adjusted diluted earnings per share attributable to SS&C to net income and diluted earnings per share attributable to SS&C, the GAAP measures we believe to be most directly comparable to adjusted net income and adjusted diluted earnings per share.
(1) Investment (gains) losses includes unrealized fair value adjustments of investments. (2) Other includes additional expenses and income that are permitted to be excluded per the terms of our Credit Agreement from Consolidated EBITDA, a financial measure used in calculating our covenant compliance. (3) An estimated effective tax rate of 22.5% has been used to adjust the provision for income taxes for the purpose of computing adjusted net income for the three and nine months ended September 30, 2026. An effective tax rate of 22% has been used to retroactively adjust the provision for income taxes for the purpose of computing adjusted net income for the three and nine months ended September 30, 2025. (4) Adjusted net income attributable to noncontrolling interest represents the proportionate share of adjusted net income of DomaniRx, LLC (a consolidated joint venture) retained by our joint venture partners. 11
Full text with the tables
Exhibit 99.1 SS&C Technologies Releases Q3 2026 Financial Results Q3 2026 GAAP
revenue $1,690.0 million, up 7.8%, Fully Diluted GAAP Earnings Per Share $0.83
Adjusted revenue $1,691.1 million, up 7.8%, Adjusted Diluted Earnings Per Share
$1.78, up 14.8% WINDSOR, CT, October 22, 2026 (BUSINESS WIRE) -- SS&C
Technologies Holdings, Inc. (NASDAQ: SSNC), a global provider of investment,
financial and healthcare technology and technology-enabled services, today
announced its financial results for the third quarter ended September 30, 2026.
Three Months Nine Months
Ended Ended
September September
30, 30,
(in
millions,
except per 2026 2025 Change 2026 2025 Change
share
data):
GAAP
Results
Revenue $1,690.0 $1,568.0 7.8% $5,032.8 $4,618.7 9.0%
Operating 409.3 365.7 11.9% 1,224.6 1,068.1 14.7%
income
Operating
income 24.2% 23.3% 90 bps 24.3% 23.1% 120 bps
margin
Net income 198.9 210.0 (5.3)% 659.8 603.8 9.3%
Diluted
earnings $0.83 $0.83 — $2.71 $2.39 13.4%
per share
Adjusted
Non-GAAP
Results
(defined in
Notes 1 - 4
below)
Adjusted $1,691.1 $1,569.0 7.8% $5,036.2 $4,621.6 9.0%
revenue
Adjusted
operating 657.6 602.5 9.1% 1,945.0 1,761.3 10.4%
income
Adjusted
operating 38.9% 38.4% 50 bps 38.6% 38.1% 50 bps
income
margin
Adjusted
consolidat… 674.8 619.0 9.0% 1,996.5 1,811.3 10.2%
EBITDA
Adjusted
consolidat… 39.9% 39.5% 40 bps 39.6% 39.2% 40 bps
EBITDA
margin
Adjusted
diluted
earnings $1.78 $1.55 14.8% $5.23 $4.52 15.7%
per
share(1)
(1) Reflects non-GAAP tax rates of 22.5% for the three and nine months ended
September 30, 2026 and 22.0% for the three and nine months ended September 30,
2025. See Note 4 for more information. Third Quarter 2026 Highlights: • Q3 2026
GAAP Revenue growth and Adjusted Revenue growth were 7.8 percent. • Q3 2026
Adjusted Organic Revenue Growth was 5.2 percent. • Net cash generated from
operating activities of $1,216.3 million for the nine months ended September 30,
2026, up 10.4 percent compared to the same period in 2025. • Returned $225.3
million to shareholders in Q3 2026, which included 1.9 million shares
repurchased for $154.8 million and $70.5 million in common stock dividends. •
Paid down $130.0 million in debt, bringing our net leverage ratio to 2.63x •
Record adjusted consolidated EBITDA of $674.8 million for Q3 2026, up 9.0
percent. Adjusted consolidated EBITDA margin for Q3 2026 was 39.9 percent. •
GAAP operating income margin for Q3 2026 was 24.2 percent and GAAP net income of
$198.9 million for Q3 2026. • Adjusted diluted earnings per share was $1.78, up
14.8 percent. • In August, SS&C increased our common stock dividend to $1.20
annually, an 11.1 percent increase. "SS&C delivered another quarter of strong
results, with Q3 organic revenue growth of 5.2%, record adjusted consolidated
EBITDA of $674.8 million, and margins of 39.9%, keeping us on track to achieve
our full-year goals," said Bill Stone, Chairman and Chief Executive Officer. "In
September, we hosted over 1,000 financial services and healthcare leaders at our
annual SS&C Deliver conference, and it was clear that holistic transformation of
our clients' operating models is a top priority. As we harness emerging
technologies like agentic AI and tokenization, SS&C is evolving in step with our
clients—partnering with them, supporting them, and shaping the future together."
1
Operating Cash Flow SS&C generated net cash from operating activities of
$1,216.3 million for the nine months ended September 30, 2026, compared to
$1,101.3 million for the same period in 2025, a 10.4% increase. SS&C ended the
third quarter with $525.4 million in cash and cash equivalents and $7,483.5
million in gross debt. SS&C’s consolidated net leverage ratio as defined in our
credit agreement stood at 2.63 times consolidated EBITDA as of September 30,
2026. SS&C’s net secured leverage ratio stood at 1.59 times consolidated EBITDA
as of September 30, 2026. Guidance
Q4 2026 FY 2026
Adjusted Revenue ($M) $1,700 – $1,740 $6,736 – $6,776
Adjusted Net Income ($M) $454 – $470 $1,726 – $1,742
Interest Expense1 ($M) $103 – $105 $417 – $419
Adjusted Diluted Earnings per Share $1.88 – $1.94 $7.11 – $7.17
Cash from Operating Activities ($M) – $1,717 – $1,817
Capital Expenditures (% of revenue) – 4.4% – 4.8%
Diluted Shares (M) 240.0 – 243.0 242.7 – 242.9
Effective Income Tax Rate (%) 21.5% – 23.5% 21.5% – 23.5%
1 Interest expense is net of deferred financing cost amortization and original
issue discount SS&C does not provide reconciliations of guidance for Adjusted
Revenues and Adjusted Net Income to comparable GAAP measures, in reliance on the
unreasonable efforts exception provided under Item 10(e)(1)(i)(B) of Regulation
S-K. SS&C is unable, without unreasonable efforts, to forecast certain items
required to develop meaningful comparable GAAP financial measures. These items
include acquisition transactions and integration, foreign exchange rate changes,
as well as other non-cash and other adjustments as defined under the Company’s
Credit agreement, that are difficult to predict in advance in order to include
in a GAAP estimate. The unavailable information could have a significant impact
on Q4 2026 and FY 2026 GAAP financial results. Non-GAAP Financial Measures
Adjusted revenue, adjusted operating income, adjusted consolidated EBITDA,
adjusted net income and adjusted diluted earnings per share are non-GAAP
measures. See the accompanying notes for the reconciliations and definitions for
each of these non-GAAP measures and the reasons our management believes these
measures provide useful information to investors regarding our financial
condition and results of operations. All references above to net income, diluted
earnings per share, adjusted operating income, adjusted consolidated EBITDA, and
adjusted diluted earnings per share are attributable to SS&C.
2
Earnings Call and Press Release
SS&C’s third quarter 2026 earnings call will take place at 5:00 p.m. eastern
time today, October 22, 2026. The call will discuss third quarter 2026 results.
Interested parties may visitinvestor.ssctech.comto access the live webcast and
view accompanying slides. The call will be available for replay via the webcast
on SS&C’s website; access:https://investor.ssctech.com/financials/quarterly-
results/default.aspx
Certain information contained in this press release, including information
relating to, among other things, the Company’s financial guidance for the fourth
quarter and full year of 2026 constitute forward-looking statements for purposes
of the safe harbor provisions under the Private Securities Litigation Reform Act
of 1995. Forward-looking statements include statements concerning plans,
objectives, goals, strategies, expectations, intentions, projections,
developments, future events, performance, underlying assumptions, and other
statements that are other than statements of historical facts. Without limiting
the foregoing, the words “believes”, “anticipates”, “plans”, “expects”,
“estimates”, “projects”, “forecasts”, “may”, “assume”, “intend”, “will”,
“continue”, “opportunity”, “predict”, “potential”, “future”, “guarantee”,
“likely”, “target”, “indicate”, “would”, “could” and “should” and similar
expressions are intended to identify forward-looking statements, although not
all forward-looking statements are accompanied by such words. Such statements
reflect management’s best judgment based on factors currently known but are
subject to risks and uncertainties, which could cause actual results to differ
materially from those anticipated. Such risks and uncertainties include, but are
not limited to, the state of the economy and the financial services industry and
other industries in which the Company’s clients operate, the Company’s ability
to realize anticipated benefits from its acquisitions, the effect of customer
consolidation on demand for the Company’s products and services, the variability
of revenue as a result of activity in the securities markets, the focus of the
Company’s business on the asset management industry, the ability to retain and
attract clients, the intensity of competition with respect to the Company’s
products and services, risks from cyber-attacks, breaches of digital security,
IT system failures and network disruptions, risks associated with third party
providers, fluctuations in the Company’s operating results, terrorist activities
and other catastrophic events, risks associated with the Company’s foreign
operations, privacy concerns relating to the collection and storage of personal
information, evolving regulations and increased scrutiny from regulators, the
Company’s ability to protect intellectual property assets and litigation
regarding intellectual property rights, delays in product development,
investment decisions concerning cash balances, tax risks, risks associated with
the Company’s joint ventures, changes in accounting standards, evolving
regulation and scrutiny from regulators, the Company’s exposure to litigation
and other claims, risks related to the Company’s substantial indebtedness, and
the market price of the Company’s stock prevailing from time to time, and the
risks discussed in the “Risk Factors” section of the Company’s most recent
Annual Report on Form 10-K and Quarterly Report on Form 10-Q, which are on file
with the Securities and Exchange Commission and can also be accessed on our
website. Such “Risk Factors”, among others, could cause actual results to differ
materially from those indicated by forward-looking statements made herein and
presented elsewhere by management from time to time. Undue reliance should not
be placed on any such forward-looking statements. Forward-looking statements
speak only as of the date on which they are made and, except to the extent
required by applicable securities laws, we undertake no obligation to update or
revise any forward-looking statements.
3
About SS&C Technologies
SS&C is a leading provider of mission-critical, AI-powered technology and
services empowering financial services and healthcare organizations to work
smarter, faster, and securely. Founded in 1986, SS&C is headquartered in
Windsor, Connecticut, and has offices worldwide. More than 23,000 financial
services and healthcare organizations, from the world's largest companies to
small and mid-market firms, rely on SS&C for expertise, scale and technology.
Follow SS&C on Twitter, LinkedIn and Facebook.
For more information
Brian Schell
Chief Financial Officer
Tel: +1-816-642-0915
E-mail:[email protected]
Justine Stone
Head of Investor Relations
Tel: +1-212-367-4705
E-mail:[email protected]
4
SS&C Technologies Holdings, Inc. and Subsidiaries Condensed Consolidated
Statements of Comprehensive Income (in millions, except per share data)
(unaudited)
Three Nine
Mont… Mon…
Ended End…
Sept… Sep…
30, 30,
Rev… 2026 2025 2026 2025
──────────────────────────────────────────────────────────────────────────────
Tec… $ 1,44… $ 1,30… $ 4,26… $ 3,8…
ser…
Lic…
mai… 241.4 258.6 768.7 771…
and
rel…
Tot… 1,69… 1,56… 5,03… 4,6…
rev…
Cost
of
rev…
Tec… 771.9 714.2 2,28… 2,0…
ser…
Lic…
mai… 104.3 106.0 314.9 311…
and
rel…
Tot…
cost 876.2 820.2 2,59… 2,3…
of
rev…
Gro… 813.8 747.8 2,43… 2,2…
pro…
Ope…
exp…
Sel…
and 154.7 144.7 466.9 449…
mar…
Res…
and 131.5 118.6 398.4 375…
dev…
Gen…
and 118.3 118.8 344.0 338…
adm…
Tot…
ope… 404.5 382.1 1,20… 1,1…
exp…
Ope… 409.3 365.7 1,22… 1,0…
inc…
Int…
exp… (107… ) (104… ) (319… ) (31… )
net
Oth…
inc… 2.9 5.3 10.8 11.4
net
Equ…
in
ear…
of (47.7 ) (11.6 ) (40.8 ) (7.7 )
unc…
aff…
net
Loss
on
ext… (0.6 ) (1.3 ) (1.0 ) (2.2 )
of
debt
Inc…
bef… 256.7 253.9 874.0 754…
inc…
tax…
Pro…
for 58.6 43.5 214.3 150…
inc…
tax…
Net 198.1 210.4 659.7 604…
inc…
Net
loss
(in…
att… 0.8 (0.4 ) 0.1 (0.9 )
to
non…
int…
Net
inc…
att…
to $ 198.9 $ 210.0 $ 659.8 $ 603…
SS&C
com…
sto…
Bas…
ear…
per
sha…
att… $ 0.85 $ 0.86 $ 2.77 $ 2.47
to
SS&C
com…
sto…
Dil…
ear…
per
sha…
att… $ 0.83 $ 0.83 $ 2.71 $ 2.39
to
SS&C
com…
sto…
Bas…
wei…
num…
of 234.6 243.8 238.0 244…
com…
sha…
out…
Dil…
wei…
num…
of
com… 240.6 252.6 243.3 253…
and
com…
equ…
sha…
out…
Net $ 198.1 $ 210.4 $ 659.7 $ 604…
inc…
Oth…
com…
(lo…
inc…
net
of
tax:
For…
cur…
exc… (6.4 ) (66.4 ) (81.1 ) 233…
tra…
adj…
Cha…
in
def… 0.2 — 0.4 —
ben…
pen…
obl…
Tot…
oth…
com…
(lo… (6.2 ) (66.4 ) (80.7 ) 233…
inc…
net
of
tax
Com… 191.9 144.0 579.0 838…
inc…
Com…
loss
(in…
att… 0.8 (0.4 ) 0.1 (0.9 )
to
non…
int…
Com…
inc…
att…
to $ 192.7 $ 143.6 $ 579.1 $ 837…
SS&C
com…
sto…
5
SS&C Technologies Holdings, Inc. and Subsidiaries Condensed Consolidated Balance
Sheets (in millions) (unaudited)
Assets September 30, December 31,
Current assets: 2026 2025
──────────────────────────────────────────────────────────────────────────────
Cash and cash $ 525.4 $ 462.1
equivalents
Funds receivable and
funds held on 3,846.5 3,799.5
behalf of clients
Accounts receivable, 1,033.7 978.7
net
Contract asset 57.4 49.2
Prepaid expenses and
other current 183.4 193.7
assets
Restricted cash 2.5 4.5
Total current assets 5,648.9 5,487.7
Property, plant and 280.3 289.5
equipment, net
Operating lease 217.9 233.3
right-of-use assets
Investments 171.3 174.4
Unconsolidated 247.3 307.7
affiliates
Contract asset 140.2 133.1
Goodwill 9,928.1 9,991.3
Intangible and other 3,781.2 4,094.7
assets, net
Total assets $ 20,415.2 $ 20,711.7
Liabilities and Equity
Current liabilities:
Current portion of $ 2,260.0 $ 25.0
long-term debt (1)
Client funds 3,846.5 3,799.5
obligations
Accounts payable 71.7 87.2
Income taxes payable — 23.3
Accrued employee
compensation and 288.1 348.9
benefits
Interest payable 16.7 31.6
Other accrued expenses 278.2 303.4
Deferred revenue 444.7 492.4
Total current 7,205.9 5,111.3
liabilities
Long-term debt, net of 5,189.5 7,408.4
current portion
Operating lease 205.4 213.2
liabilities
Other long-term 198.4 190.2
liabilities
Deferred income taxes 848.3 846.8
Total liabilities 13,647.5 13,769.9
SS&C stockholders' 6,698.7 6,887.6
equity
Noncontrolling interest 69.0 54.2
Total equity 6,767.7 6,941.8
Total liabilities and $ 20,415.2 $ 20,711.7
equity
(1) $2.0 billion of Senior Notes has been classified as current given the stated
maturity of September 30, 2027. We are actively addressing this maturity and
believe refinancing the Senior Notes is probable of occurring during the 4 th
quarter of 2026.
6
SS&C Technologies Holdings, Inc. and Subsidiaries Condensed Consolidated
Statements of Cash Flows (in millions) (unaudited)
Cash flow from Nine Months Ended
operating September 30,
activities: 2026 2025
──────────────────────────────────────────────────────────────────────────────
Net income $ 659.7 $ 604.7
Adjustments to
reconcile net
income to
net cash provided
by operating
activities:
Depreciation and 544.7 521.1
amortization
Equity in earnings
of unconsolidated 40.8 7.7
affiliates, net
Distributions
received from 16.9 —
unconsolidated
affiliates
Stock-based
compensation 185.8 172.9
expense
Unrealized net
losses on 2.2 2.4
investments
Amortization of
debt financing 5.5 4.9
costs
Loss on
extinguishment of 1.0 2.2
debt
Loss on sale or
disposition of 2.0 0.5
property
and equipment
Deferred income 1.3 46.8
taxes
Provision for 15.0 12.0
credit losses
Changes in
operating assets
and
liabilities,
excluding effects
from
acquisitions:
Accounts receivable (73.3 ) (54.5 )
Prepaid expenses (14.6 ) 22.0
and other assets
Contract assets (15.0 ) (29.1 )
Accounts payable (31.5 ) (16.7 )
Accrued expenses
and other (72.6 ) (48.1 )
liabilities
Income taxes (0.3 ) (98.8 )
prepaid and payable
Deferred revenue (51.3 ) (48.7 )
Net cash provided
by operating 1,216.3 1,101.3
activities
Cash flow from
investing
activities:
Business
acquisitions, net (0.2 ) (5.9 )
of cash
acquired
Additions to
property and (37.0 ) (70.3 )
equipment
Proceeds from sale
of property and 2.2 5.7
equipment
Additions to
capitalized (190.2 ) (155.5 )
software
Investments in (7.5 ) (2.5 )
securities
Proceeds from sales
/ maturities of 7.7 0.8
investments
Distributions
received from
(contributions to) 2.6 (9.8 )
unconsolidated
affiliates
Collection of other
non-current 8.1 7.9
receivables
Net cash used in
investing (214.3 ) (229.6 )
activities
Cash flow from
financing
activities:
Cash received from 450.0 122.0
debt borrowings
Repayments of debt (440.0 ) (545.1 )
Net (decrease)
increase in client (323.3 ) 269.4
funds
obligations
Proceeds from
exercise of stock 86.0 362.4
options
Withholding taxes
paid related to
equity (81.7 ) (73.2 )
award net share
settlement
Purchases of common (760.5 ) (717.3 )
stock for treasury
Dividends paid on (199.8 ) (188.3 )
common stock
Proceeds from
(distributions to) 14.9 (21.8 )
noncontrolling
interests
Net cash used in
financing (1,254.4 ) (791.9 )
activities
Effect of exchange
rate changes on
cash, (9.6 ) 9.8
cash equivalents
and restricted cash
Net (decrease)
increase in cash,
cash (262.0 ) 89.6
equivalents and
restricted cash
Cash, cash
equivalents and
restricted
cash and cash 3,573.8 3,370.5
equivalents,
beginning of
period
Cash, cash
equivalents and
restricted $ 3,311.8 $ 3,460.1
cash and cash
equivalents, end of
period
Reconciliation of
cash, cash
equivalents
and restricted cash
and cash
equivalents:
Cash and cash $ 525.4 $ 388.3
equivalents
Restricted cash and 2.5 2.5
cash equivalents
Restricted cash and
cash equivalents
included in funds
receivable and 2,783.9 3,069.3
funds
held on behalf of
clients
$ 3,311.8 $ 3,460.1
7
SS&C Technologies Holdings, Inc. and Subsidiaries Disclosures Relating to Non-
GAAP Financial Measures Note 1. Reconciliation of Revenues to Adjusted Revenues
Adjusted revenues represents revenues adjusted to include a) amounts that would
have been recognized if deferred revenue were not adjusted to fair value at the
date of acquisition and b) amounts that would have been recognized if not for
adjustments to deferred revenue and retained earnings related to the adoption of
ASC 606. Adjusted revenues is presented because we use this measure to evaluate
performance of our business against prior periods and believe it is a useful
indicator of the underlying performance of our business. Adjusted revenues is
not a recognized term under generally accepted accounting principles (“GAAP”).
Adjusted revenues does not represent revenues, as that term is defined under
GAAP, and should not be considered as an alternative to revenues as an indicator
of our operating performance. Adjusted revenues as presented herein is not
necessarily comparable to similarly titled measures presented by other
companies. Below is a reconciliation of adjusted revenues to revenues, the GAAP
measure we believe to be most directly comparable to adjusted revenues.
Three Nine
Months Months
Ended Ended
(in Septem… Septemb…
millio… 2026 30, 2025 2026 30, 2025
──────────────────────────────────────────────────────────────────────────────
Revenu… $ 1,690.0 $ 1,568.0 $ 5,032.8 $ 4,618.7
Purcha…
accoun…
adjust… 1.1 1.0 3.4 2.9
impact
on
revenue
Adjust… $ 1,691.1 $ 1,569.0 $ 5,036.2 $ 4,621.6
revenu…
The following is a breakdown of technology-enabled services and license,
maintenance and related revenues and adjusted technology-enabled services and
license, maintenance and related revenues.
Three Nine
Months Months
Ended Ended
(in Septem… Septemb…
millio… 2026 30, 2025 2026 30, 2025
──────────────────────────────────────────────────────────────────────────────
Techno… $ 1,448.6 $ 1,309.4 $ 4,264.1 $ 3,847.0
servic…
Licens…
mainte… 241.4 258.6 768.7 771.7
and
related
Total $ 1,690.0 $ 1,568.0 $ 5,032.8 $ 4,618.7
revenu…
Techno… $ 1,449.8 $ 1,310.4 $ 4,267.6 $ 3,849.9
servic…
Licens…
mainte… 241.3 258.6 768.6 771.7
and
related
Total
adjust… $ 1,691.1 $ 1,569.0 $ 5,036.2 $ 4,621.6
revenu…
8
Note 2. Reconciliation of Operating Income to Adjusted Operating Income Adjusted
operating income represents operating income adjusted for amortization of
intangible assets, stock-based compensation, purchase accounting adjustments for
deferred revenue and related costs, ASC 606 adoption impact and other expenses.
Adjusted operating income is presented because we use this measure to evaluate
performance of our business and believe it is a useful indicator of our
underlying performance. Adjusted operating income is not a recognized term under
GAAP. Adjusted operating income does not represent operating income, as that
term is defined under GAAP, and should not be considered as an alternative to
operating income as an indicator of our operating performance. Adjusted
operating income as presented herein is not necessarily comparable to similarly
titled measures by other companies. The following is a reconciliation between
adjusted operating income and operating income, the GAAP measure we believe to
be most directly comparable to adjusted operating income.
Three Nine
Mont… Mont…
Ended Ended
(in Sept… Sept…
mil… 2026 30, 2025 2026 30, 2025
──────────────────────────────────────────────────────────────────────────────
Ope… $ 409.3 $ 365.7 $ 1,22… $ 1,06…
inc…
Amo…
of 165.1 157.8 491.3 467.8
int…
ass…
Sto… 62.1 60.0 185.8 172.9
com…
Acq… 0.3 3.1 1.8 6.1
rel…
Fac…
and 13.8 12.0 32.4 36.2
wor…
res…
Oth… 8.9 4.3 13.8 12.6
(1)
Adj…
ope… $ 659.5 $ 602.9 $ 1,94… $ 1,76…
inc…
Adj…
ope…
inc…
att… (1.9 ) (0.4 ) (4.7 ) (2.4 )
to
non…
int…
(2)
Adj…
ope…
inc…
att… $ 657.6 $ 602.5 $ 1,94… $ 1,76…
to
SS&C
com…
sto…
(1) Other includes additional expenses and income that are permitted to be
excluded per the terms of our Credit Agreement from Consolidated EBITDA, a
financial measure used in calculating our covenant compliance. (2) Adjusted
operating income attributable to noncontrolling interest represents the
proportionate share of adjusted operating income of DomaniRx, LLC (a
consolidated joint venture) retained by our joint venture partners.
9
Note 3. Reconciliation of Net Income to EBITDA, Consolidated EBITDA and Adjusted
Consolidated EBITDA EBITDA represents net income before interest expense, income
taxes, depreciation and amortization. Consolidated EBITDA, defined under our
Credit Agreement entered into in April 2018, as amended, is used in calculating
covenant compliance, and is EBITDA adjusted for certain items. Consolidated
EBITDA is calculated by subtracting from or adding to EBITDA items of income or
expense described below. Adjusted Consolidated EBITDA is calculated by
subtracting acquired EBITDA (as defined below) from Consolidated EBITDA. EBITDA,
Consolidated EBITDA and Adjusted Consolidated EBITDA are presented because we
use these measures to evaluate performance of our business and believe them to
be useful indicators of an entity’s debt capacity and its ability to service
debt. EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA are not
recognized terms under GAAP and should not be considered in isolation or as
alternatives to operating income, net income or cash flows from operating
activities as indicators of our operating performance. These measures are not
necessarily comparable to similarly titled measures by other companies. The
following is a reconciliation of EBITDA, Consolidated EBITDA and Adjusted
Consolidated EBITDA to net income.
Th… Ni… Tw…
Mo… Mo… Mo…
En… En… En…
(… Se… Se… Se…
m… 20… 30, 20… 20… 30, 20… 2… 30,
──────────────────────────────────────────────────────────────────────────────
N… $ 19… $ 21… $ 65… $ 60… $ 85…
i…
I…
e… 10… 10… 31… 31… 43…
n…
P…
f… 58… 43… 21… 15… 24…
i…
t…
D…
a… 18… 17… 54… 52… 72…
a…
E… 54… 53… 1,… 1,… 2,…
S… 62… 60… 18… 17… 27…
c…
A…
E…
a… — — — — 2.8
c…
s…
(…
E…
in
e…
of 47… 11… 40… 7.7 42…
u…
a…
n…
I…
l… 0.6 (3… ) (1… ) (1… ) (1… )
(…
(…
F…
a… 13… 12… 32… 36… 41…
w…
r…
A… (2… ) 3.8 (1… ) 6.8 3.5
r…
O… 8.6 1.9 16… 12… 54…
(…
C… $ 67… $ 61… $ 2,… $ 1,… $ 2,…
E…
A…
E…
a… — — — — (2… )
c…
s…
(…
A…
C… $ 67… $ 61… $ 2,… $ 1,… $ 2,…
E…
A…
C…
E…
a… (1… ) (0… ) (4… ) (2… ) (5… )
to
n…
i…
(…
A…
C…
E…
a… $ 67… $ 61… $ 1,… $ 1,… $ 2,…
to
S…
c…
s…
(1) Acquired EBITDA reflects the EBITDA impact of significant businesses that
were acquired during the last twelve months as if the acquisition occurred at
the beginning of the trailing twelve-month period, as well as cost savings
enacted in connection with acquisitions. (2) Investment gains includes
unrealized fair value adjustments of investments and dividend income received on
investments. (3) Other includes additional expenses and income that are
permitted to be excluded per the terms of our Credit Agreement from Consolidated
EBITDA, a financial measure used in calculating our covenant compliance, and
includes a loss on the sale of fixed assets of $33.3 million during the twelve
months ended September 30, 2026. (4) Adjusted Consolidated EBITDA attributable
to noncontrolling interest represents the proportionate share of adjusted
Consolidated EBITDA of DomaniRx, LLC (a consolidated joint venture) retained by
our joint venture partners.
10
Note 4. Reconciliation of Net Income to Adjusted Net Income and Diluted Earnings
Per Share Attributable to SS&C to Adjusted Diluted Earnings Per Share
Attributable to SS&C Adjusted net income and adjusted diluted earnings per share
attributable to SS&C represent net income and earnings per share attributable to
SS&C before amortization of intangible assets and deferred financing costs,
stock-based compensation, purchase accounting adjustments and other items. We
consider adjusted net income and adjusted diluted earnings per share
attributable to SS&C to be important to management and investors because they
represent our operational performance exclusive of the effects of amortization
of intangible assets and deferred financing costs, stock-based compensation,
purchase accounting adjustments, loss on extinguishment of debt and other items,
that are not operational in nature or comparable to those of our competitors.
Adjusted net income and adjusted diluted earnings per share are not recognized
terms under GAAP. Adjusted net income and adjusted diluted earnings per share do
not represent net income or diluted earnings per share, as those terms are
defined under GAAP, and should not be considered as alternatives to net income
or diluted earnings per share as indicators of our operating performance.
Adjusted net income and adjusted diluted earnings per share attributable to SS&C
as presented herein are not necessarily comparable to similarly titled measures
presented by other companies. Below is a reconciliation of adjusted net income
and adjusted diluted earnings per share attributable to SS&C to net income and
diluted earnings per share attributable to SS&C, the GAAP measures we believe to
be most directly comparable to adjusted net income and adjusted diluted earnings
per share.
(in
mil… Three Nine
exc… Mont… Mont…
per Ended Ended
sha… Sept… Sept…
dat… 2026 30, 2025 2026 30, 2025
──────────────────────────────────────────────────────────────────────────────
GAAP
– $ 198.1 $ 210.4 $ 659.7 $ 604.7
Net
inc…
Amo…
of 165.1 157.8 491.3 467.8
int…
ass…
Sto… 62.1 60.0 185.8 172.9
com…
Equ…
in
ear…
of 47.7 11.6 40.8 7.7
unc…
aff…
net
Inv…
los… 2.7 (1.1 ) 1.4 2.4
(ga…
(1)
Fac…
and 13.8 12.0 32.4 36.2
wor…
res…
Acq… (2.8 ) 3.8 (1.3 ) 6.8
rel…
Oth… 11.0 4.4 23.6 21.1
(2)
Inc…
tax (66.6 ) (67.0 ) (156… ) (173… )
eff…
(3)
Adj…
net $ 431.1 $ 391.9 $ 1,27… $ 1,14…
inc…
Adj…
net
inc…
att… (2.1 ) (0.5 ) (4.9 ) (3.2 )
to
non…
int…
(4)
Adj…
net
inc…
att… $ 429.0 $ 391.4 $ 1,27… $ 1,14…
to
SS&C
com…
sto…
Adj…
dil…
ear…
per
sha… $ 1.78 $ 1.55 $ 5.23 $ 4.52
att…
to
SS&C
com…
sto…
GAAP
dil…
ear…
per
sha… $ 0.83 $ 0.83 $ 2.71 $ 2.39
att…
to
SS&C
com…
sto…
Dil…
wei… 240.6 252.6 243.3 253.1
sha…
out…
(1) Investment (gains) losses includes unrealized fair value adjustments of
investments. (2) Other includes additional expenses and income that are
permitted to be excluded per the terms of our Credit Agreement from Consolidated
EBITDA, a financial measure used in calculating our covenant compliance. (3) An
estimated effective tax rate of 22.5% has been used to adjust the provision for
income taxes for the purpose of computing adjusted net income for the three and
nine months ended September 30, 2026. An effective tax rate of 22% has been used
to retroactively adjust the provision for income taxes for the purpose of
computing adjusted net income for the three and nine months ended September 30,
2025. (4) Adjusted net income attributable to noncontrolling interest represents
the proportionate share of adjusted net income of DomaniRx, LLC (a consolidated
joint venture) retained by our joint venture partners.
11